Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitor

• 收藏
• 分享

专利权人:

Eli Lilly and Company

发明人:

Patrick Cornelious May,Dustin James Mergott

申请号：

US15503027

公开号：

US09999624B2

申请日:

2015.09.08

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention provides a method of treating a cognitive or neurodegenerative disease, comprising administering to a patient in need of such treatment an effective amount of a compound of the formula I, or a pharmaceutically acceptable salt thereof； in combination with an effective amount of an anti-N3pGlu Abeta monoclonal antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/